The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 327.00
Bid: 326.00
Ask: 328.00
Change: 1.00 (0.31%)
Spread: 2.00 (0.613%)
Open: 326.00
High: 328.00
Low: 325.00
Prev. Close: 326.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Resolutions of AGM- Replacement

23 May 2022 07:17

RNS Number : 4001M
Bank of Cyprus Holdings PLC
23 May 2022
 

 

Announcement

 

Resolutions of the Shareholders Annual General Meeting (AGM)

 

Nicosia, 23 May 2022

 

 

 

This announcement replaces the "Resolutions of the Shareholders Annual General Meeting (AGM)" announcement released on 20 May 2022 at 12.36 pm (UK time) under RNS No 3010M which contained a typographical error and should be disregarded.

 

 

The Annual General Meeting ("AGM") of the Bank of Cyprus Holdings Public Limited Company ("the Company" or "the Bank") was held at the Company's Headquarters on Friday, 20 May 2022. The AGM was attended by 17 Shareholders & Depository Interest Holders, either in person or by proxy, who represented 138.151.974 shares, that is 30,96% of the total issued share capital of the Company.

 

 

Ordinary Business

 

The AGM considered the Financial Statements for the year ended 31 December 2021 together with the reports of the Directors and the Auditors and fixed the ordinary remuneration of the Members of the Board.

 

The AGM authorised the Board of Directors to fix the remuneration of PricewaterhouseCoopers as the Company's Statutory Auditors for the year 2022. 

 

The following Directors were re-elected to the Board of Directors:

 

a) Efstratios-Georgios (Takis) Arapoglou

b) Lyn Grobler

c) Arne Berggren

d) Paula Hadjisotiriou

e) Panicos Nicolaou

f) Maria Philippou

g) Nicolaos Sofianos

h) Ioannis Zographakis

i) Constantine Iordanou

j) Eliza Livadiotou

 

The Board notes that following today's shareholder vote at the 2022 AGM, Mr. Maksim Goldman and Dr. Michael Heger have not been re-elected to the Board of the Company. The Board also notes that while Mr Arne Berggren was re-elected receiving 98,825,604 votes representing 71,67% of total valid votes cast, more than 20% of the votes cast were against his re-election. In accordance with the UK Corporate Governance Code, the Board intends to engage with shareholders and will provide an update on the views received from shareholders as appropriate.

 

The AGM received and considered the Annual Remuneration Report of the Remuneration Committee for the year ended 31 December 2021 and the 2022 Remuneration Policy.

 

Special Business

 

The AGM further resolved to:

 

· To consider and authorise the Directors to establish and implement a long-term incentive plan (the "2022 LTIP"

· To consider and authorise the Directors to allot and issue shares

· To consider and authorise the Directors to dis-apply the pre-emption provisions of Section 1022 of the Companies Act

· To consider and authorise the Directors to dis-apply the pre-emption provisions of Section 1022 of the Companies Act in respect of financing a transaction

· To consider and authorise the Directors to issue, allot, grant options over or otherwise dispose of ordinary shares on the conversion or exchange of Additional Tier 1 Contingent Equity Conversion Notes

· To consider and authorise the Directors to dis-apply the pre-emption provisions of Section 1022 of the Companies Act in respect of shares issued pursuant to Resolution 10

· To consider and authorise the Directors to make market purchases of the Company's ordinary shares

· To consider and determine the re-issue price range at which treasury shares may be re-allotted

· To consider and allow for the convening of an Extraordinary General Meeting by at least 14 clear days' notice

· To consider and approve the amendment of the Company's Articles of Association by the deletion of the existing Article 102 and the adoption of a new Article 102, permitting the approval of board resolutions in writing (including by a majority board decision)

 

as per the provisions made in the Notice of Annual General Meeting issued on 15 April 2022.

 

The above Special Business resolutions are valid until the next AGM or 19 August 2023, whichever is the earlier.

 

In accordance with Listing Rule 14.3.6, copies of the resolutions that do not constitute ordinary business at an annual general meeting will be submitted to the National Storage Mechanism and will be available after 6:00 pm (Cyprus Time).

 

A table setting out the voting results for each of the resolutions is included in the Appendix attached. It is noted that a vote withheld is not a vote in law and is not counted in the calculation of the proportion of the votes for and against the resolution.

 

Appendix: List of resolutions approved by the AGM (numbering as per Notice of Annual General Meeting issued on 15 April 2022)

Resolution Number

Votes For

Votes Against

 

Approved Yes/No

 Number of Shares

% of total valid votes cast

Number of Shares

% of total valid votes cast

Votes Withheld

1

137,881,926

100.00

0

0.00

0

Yes

2

137,881,926

100.00

0

0.00

0

Yes

3

137,881,926

100.00

0

0.00

0

Yes

4(a)

120,057,939

87.07

17,822,987

12.93

1,000

Yes

4(b)

137,880,926

100.00

0

0.00

1,000

Yes

4(c)

98,825,604

71.67

39,055,322

28.33

1,000

Yes

4(d)

20,136,658

14.60

117,744,268

85.40

1,000

No

4(e)

137,880,926

100.00

0

0.00

1,000

Yes

4(f)

52,295,080

37.93

85,585,846

62.07

1,000

No

4(g)

137,880,926

100.00

0

0.00

1,000

Yes

4(h)

137,880,926

100.00

0

0.00

1,000

Yes

4(i)

137,880,926

100.00

0

0.00

1,000

Yes

4(j)

137,880,926

100.00

0

0.00

1,000

Yes

4(k)

137,880,926

100.00

0

0.00

1,000

Yes

4(l)

137,880,926

100.00

0

0.00

1,000

Yes

5

136,089,417

98.70

1,791,509

1.30

1,000

advisory, non-binding resolution

6

137,881,926

100.00

0

0.00

0

Yes

7

137,779,670

99.93

102,256

0.07

0

Yes

8

137,880,926

100.00

1,000

0.00

0

Yes

9

137,880,926

100.00

1,000

0.00

0

Yes

10

137,881,926

100.00

0

0.00

0

Yes

11

137,881,926

100.00

0

0.00

0

Yes

12

137,881,926

100.00

0

0.00

0

Yes

13

137,881,926

100.00

0

0.00

0

Yes

14

136,089,417

98.70

1,792,509

1.30

0

Yes

15

137,881,926

100.00

0

0.00

0

Yes

 

 

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. At 31 March 2022, the Bank of Cyprus Group operated through a total of 86 branches in Cyprus, of which 11 operated as cash offices. Bank of Cyprus also has representative offices in Russia, Ukraine and China. At 31 March 2022, the Group's Total Assets amounted to €25.1 bn and Total Equity was €2.1 bn. The Bank of Cyprus Group employed 3,395 staff worldwide. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUOANRURUVURR
Date   Source Headline
2nd May 20247:28 amRNSBOCH - Transactions in Own Shares
2nd May 20247:20 amRNSBOCH – Total voting rights and Capital
30th Apr 202410:19 amRNSAppointments of New Directors
30th Apr 20247:02 amRNSTransaction in Own Shares
29th Apr 20247:15 amRNSBOCH - Transactions in Own Shares
26th Apr 20241:21 pmRNSDate of announcement of 1Q2024 FR
26th Apr 20247:03 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:26 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:00 amRNSIssue of Green Senior Preferred Notes by BOC PCL
24th Apr 20247:00 amRNSBOCH - Transaction in Own Shares
24th Apr 20247:00 amRNSTR1 Notification - Helikon
24th Apr 20247:00 amRNSTR1 Notification -Helikon
23rd Apr 20247:25 amRNSBOCH - Transactions in Own Shares
22nd Apr 20247:27 amRNSBOCH - Transactions in Own Shares
19th Apr 20247:41 amRNSLaunch of share buyback programme
12th Apr 202410:02 amRNSNotice of AGM
5th Apr 20247:20 amRNS2023 Pillar 3 Disclosures
2nd Apr 20241:21 pmRNSTR1 Notification of Holdings - OSOME
2nd Apr 202412:59 pmRNSTR1 Notification of Holdings - OSOME
28th Mar 20242:24 pmRNSBOC Annual Financial Report 2023 Announcement
28th Mar 20241:31 pmRNSBOCH Annual Financial Report 2023 Announcement
28th Mar 20241:30 pmRNSFY2023 Investor Presentation Announcement
28th Mar 20241:30 pmRNSFY2023 Group Financial Results
20th Mar 20247:00 amRNSAnnouncement of Distribution
15th Mar 20249:21 amRNSDate of Announcement of Audited FY2023 FS
19th Feb 20247:01 amRNSDoc re. (Prelim FY2023 Investor Presentation)
19th Feb 20247:00 amRNSPreliminary FY2023 Group Financial Results
6th Feb 20248:41 amRNSDate of announcement of Preliminary FY2023 FR
22nd Dec 20239:09 amRNSRevised Date of AGM
20th Dec 20238:32 amRNSChanges in the composition of the BOD & Committees
13th Dec 20237:00 amRNSEU-wide Transparency Exercise 2023
11th Dec 20232:51 pmRNSChanges in the composition of the BOD
29th Nov 202310:28 amRNSDecision to call AT1 Capital Securities
29th Nov 20238:19 amRNSDate of Annual General Meeting
20th Nov 20239:58 amRNSAppointment of New Director
13th Nov 20237:00 amRNSDoc re. (9M2023 Investor Presentation)
13th Nov 20237:00 amRNS9M2023 Group Financial Results
27th Oct 20237:17 amRNSDate of announcement of 9M2023 FR
24th Oct 202312:41 pmRNSTR1 Notification - Caius
13th Oct 202312:27 pmRNSChanges in the composition of the BODs
27th Sep 20238:28 amRNSDirectorate Change
31st Aug 20237:37 amRNSChanges in the composition of BOD
11th Aug 20239:55 amRNSAppointment of new director
21st Jul 202310:43 amRNSDate of announcement of 1H2023 FR
18th Jul 20234:43 pmRNSIssue of Senior Preferred Notes
3rd Jul 202311:48 amRNSBuyback of Additional Tier 1 Capital Securities
23rd Jun 202312:48 pmRNSComposition of the Boards of Directors
20th Jun 202312:22 pmRNSResults of Additional Tier 1 Tender Cash Offer
19th Jun 202312:34 pmRNSTR1 Notification of Major Holdings - Caius
13th Jun 20233:43 pmRNSRefinancing of AT1 Capital Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.